Company Information

Company Astellas Pharma Inc.
www.astellas.com
Type:
Company
Country:
Japan
Sector:
Pharmaceuticals & Biotechnology
Ownership:
Publicly Listed
Global Compact Status:
Active
Participant Since
28 October 2011
Letter of Commitment
Next Communication on Progress (COP) due on:
31 July 2025

Financial Information


Forward Faster

Affiliated Subsidiaries

Country Company Name
Denmark Astellas Pharma a/s

Communication On Progress

Published On Title Level/Status
25-Jul-2024 2024 Communication on Progress Submitted
28-Feb-2024 2023 Communication on Progress Submitted
29-Nov-2022 Communication on Progress, 2022 Active
29-Nov-2022 Communication on Progress 2022 Active
01-Dec-2021 Annual Report 2021 for Communication on Progress Active
09-Dec-2020 Annual Report 2020 for Communication on Progress Active
08-Jan-2020 Annual Report 2019 for Communication on Progress Active
18-Sep-2019 Grace Letter Not applicable
12-Oct-2018 Communication on Progress Active
13-Oct-2017 Annual Report 2017 for Communication on Progress Details Active
14-Oct-2016 Annual Report 2016 for Communication on Progress Active
15-Oct-2015 Communication on Progress Active
15-Oct-2014 Astellas Annual Report 2014 Active
18-Oct-2013 Communication on Progress Active
18-Oct-2012 Astellas Annual Report 2012 Active

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.